Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Usual interstitial pneumonia].

J M Hougardy1, A Ocmant, S Place

  • 1Services de Médecine Interne Générale, Hôpital Erasme, ULB, Bruxelles.

Revue Medicale De Bruxelles
|August 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiparametric analysis of vaccine-induced B and T cell responses for optimal evaluation of memory immune responses to Bordetella pertussis in children.

Vaccine·2026
Same author

[Febrile dyspnea in a 20 year-old woman].

La Revue de medecine interne·2023
Same author

[Skin ulcerations, melanoderma and dyspnea].

La Revue de medecine interne·2023
Same author

Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays.

Journal of clinical microbiology·2022
Same author

Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2021
Same author

Pulmonary and renal tolerance of cisplatin-based regimens combining intravenous and endotracheal routes for lung cancer treatment in mice.

International journal of pharmaceutics·2021
Same journal

[Breast cancer screening : a tool for informed decision making].

Revue medicale de Bruxelles·2018
Same journal

[Breast cancer screening : present situation and prospects].

Revue medicale de Bruxelles·2018
Same journal

[Guidelines in medical imaging : objectives, limits and radiation protection].

Revue medicale de Bruxelles·2018
Same journal

[How to avoid overmedicalization of the elderly patient ?]

Revue medicale de Bruxelles·2018
Same journal

[Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention].

Revue medicale de Bruxelles·2018
Same journal

[New strategies in specific care for benign prostatic hypertrophy in older men].

Revue medicale de Bruxelles·2018
See all related articles

Idiopathic pulmonary fibrosis (IPF) can be misdiagnosed as systemic lupus erythematosus. Early diagnosis and new treatments are crucial for this rare lung disease with a poor prognosis.

Area of Science:

  • Pulmonology
  • Rheumatology
  • Pathology

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a rare interstitial lung disease with a 3-6 per 100,000 prevalence in the US.
  • IPF presents insidiously, has a poor prognosis, and a median survival of 2.8 years.
  • Accurate diagnosis of IPF is challenging, often requiring exclusion of other interstitial lung diseases.

Observation:

  • A 49-year-old woman was initially misdiagnosed with systemic lupus erythematosus.
  • The diagnostic process involved collaboration between clinicians, radiologists, and pathologists.
  • New classifications and treatment strategies are emerging for IPF.

Findings:

  • The case highlights diagnostic challenges in distinguishing IPF from other conditions.
  • Multidisciplinary expert coordination is essential for accurate IPF diagnosis.

Related Experiment Videos

  • Conventional immunosuppressants show limited efficacy in IPF management.

    • Implications:

    • Improved diagnostic criteria and multidisciplinary approaches can enhance IPF detection.
    • Emerging treatments offer potential for better outcomes in IPF patients.
    • Further research into IPF pathogenesis and novel therapies is warranted.